OBJECTIVE To develop a supercritical fluid chromatography method for the separation of atorvastatin calcium and its enantiomer, meanwhile assaying the enantiomer. METHODS Atorvastatin calcium and its enantiomer were separated on a ACQUITY UPC2 Trefoil CEL2 column(3.0 mm×150 mm, 2.5 μm) maintained at 45 ℃ with the mobile phase containing a mixture of CO2 and methanol with 0.1% TFA(78∶22, V/V) at 1.5 mL·min-1, and the detection wavelength was set at 244 nm. The back pressure was set at 13.8 MPa. RESULTS The enantiomer and atorvastatin calcium were separated successfully in 5 min with a resolution factor of 4.1. Good linear relationship was established between the peak response and the concentration in the range of 2.5-50 μg·mL-1 for enantiomer(r2=0.999 9, n=6), the quantitative limit(S/N=10) was 2.5 μg·mL-1, and the detection limit(S/N=3) was 1.0 μg·mL-1. The spiked recovery of the enantiomer was 100.40%(n=9). CONCLUSION The proposed method shows high accuracy, repeatability and stability. It can be employed for the quality control and stability research of the enantiomer of atorvastatin calcium.
ZHANG Shao-min, JIN Wei, ZHANG Chen-han, YANG Yong-jian.
Chiral Separation of Atorvastatin Calcium and Its Enantiomeric Impurity by Supercritical Fluid Chromatography[J]. Chinese Pharmaceutical Journal, 2018, 53(21): 1856-1860 https://doi.org/10.11669/cpj.2018.21.010
[1] ZHANG X F, HOU X Q, DENG F X, et al. Determination of the related substances in atorvastatin calcium by HPLC[J]. Chin J Pharm Anal(药物分析杂志), 2014, 34(8):1504-1508. [2] JIN W, LIN H, CHEN Y, et al. Chiral separation of ezetimibe and R-enantiomer by supercritical fluid chromatography[J]. Chin Pharm J(中国药学杂志), 2015, 50(1):68-71. [3] YANG W Z, ZHANG Y B. Supercritical fluid chromatography for separation and preparation of tautomeric 7-epimeric spiro oxindole alkaloids from uncariamacrophylla[J]. J Pharm Biomed Anal, 2017,(134):352-360. [4] WANG Q L, SHI C Y, WANG W Q, et al. Content determination of enantiomer in Atorvastatin Calcium Tablet by HPLC using chiral stationary phase[J]. J China Pharm(中国药房), 2013, 24(16):1521-1523. [5] ZHANG Y. Analysis of the 3S,5S-enantiomer in atorvastatin calcium[D]. Shanghai: Fudan University, 2014.